Volume 12 - Issue 9 - September, 2004
Verification of Correct Patient, Procedure, and Site at Govenor Juan F. Luis Hospital and Medical Center: The Failure Mode and E
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 1720 reads
One of the new National Patient Safety Goals per the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Standards is verifying the correct patient, procedure, and procedure site when performing an invasive procedure. With extensive research of this standard, we discovered that not only is the standard required within an operating suite, but also a cardiovascular and/or catheterization suite, and any other department where a patient under goes an invasive procedure. While preparing for our most recent survey (June 2004) by the Joint Commission, the Governor Juan F. Luis Hospi
Single Operator Deployment of Vasoseal ES®: The Experience of Skaggs Community Health Center
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 4258 reads
Vascular sealing devices have made their way into most cath labs in North America. Technology and development in this arena continues to improve and expand the horizons of hemostasis management. Patient comfort, efficiency, and cost-effectiveness are just a few of the reasons for the development of these devices. Although the techniques and equipment used vary among the different devices, the goal is the same: rapid hemostasis.
The Skaggs Community Health Center cath lab opened in June of 1999. We are a one-unit diagnostic and interventional cath lab, with 2 RNs and 3 technologists, and
Cath Lab Digest Email Discussion Group
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 1909 reads
Question 1: Defibrillation by non-nursing staff?
How does your hospital policy on defibrillation address non-nursing personnel in the cath lab? Are your rad techs or resp therapists allowed to defibrillate if they are ACLS certified? Is that a department policy or covered under a hospital policy?
Question 2: Emergency cases after hours?
Other than an acute MIs, what are considered emergency cases after normal operating hours? Do you have specific criteria, and do your interventionalists follow them?
Group Members Respond to…
Question 1: Defibrillation by n
Drug-eluting Stent Solutions: Examining the Anti-Proliferative Drug Paclitaxel
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 2427 reads
Dr. Heldman was the first to demonstrate effective reduction of coronary restenosis in an animal model with a prototype drug eluting stent. His clinical interests include the treatment and prevention of coronary restenosis; complex coronary interventions, coronary stenting, diseases of the aorta and peripheral vascular disease. His research interests include coronary stent design; coronary local drug delivery for treatment and prevention of restenosis; cardiovascular gene therapy; stem cell myogenesis; and cardiac magnetic resonance imaging (MRI). Dr. Heldman has published extensively in s
Really, this Meeting is Different St.Luke's Medical Center's 4th Annual "Understanding Cardiovascular Disease"
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 1898 reads
Four years ago, a group of cardiovascular nurses and technicians from St. Luke’s Medical Center Milwaukee came together to discuss the value of continuing education, the difficulty and expense of obtaining CEUs, and the benefits and limitations of national meetings. This group of professionals began to create a list detailing what they believed would constitute the ideal meeting. The group decided the ideal meeting would be interactive and hands-on. The hands-on sessions would be proctored by experts that would explain the limitations of technology while identifying the pearls learned from y
Sea Change in Cardiovascular Information Management Predicted
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 1871 reads
What are the areas of change you see for the market?
As a company, Heartlab now has approximately 275 customers, which are principally in North America, although we are rapidly expanding into Asia and Europe. I bring this up because we have been hearing similar needs voiced by many of our customers. They want to take the information collected in the core diagnostic or interventional areas of the hospital, and make it available wherever physicians and technical staff happen to be. The trend now is to require delivery of high-quality documentation and high-quality images outside of the
Cath Lab Shortages and Solutions
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 2137 reads
Who out there has not had to deal with the staffing shortages facing not only cardiology, but also the healthcare field overall? If you haven’t, then you are one of the lucky few. The nursing shortage alone is expected to hit healthcare hard. Couple that with the shortage of radiology technologists, and it has us all pulling out our hair, wondering where we are going to get our staff.
What do we do to make sure we have competent, adequately-trained staff? Clearly, we still have to take care of our patients and not compromise patient care. I will share with you what my organizations an
The 10 Minute Interview with Heidi N. Bonneau, RN, MS
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 2380 reads
Why did you choose to work in the invasive cardiology field?
In 1987, a job opportunity came my way via a graduate school alumnus, Mary Murphy, who was already working at the San Francisco Heart Institute. The field was in its early stages and filled with excitement, and I wanted to be a part of it.
Can you describe your role in the CV lab at that time?
My role focused largely on education and research. I provided support to the family members of the patient along with updates as the case was progressing, did discharge planning and education with patient/family, and ma
Shore Memorial Hospital: Faster and More Efficient Workflow
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 2016 reads
Shore Memorial is the only local hospital offering a clinical affiliation with the University of Pennsylvania Health System. Through this affiliation, cardiologists from PENN Cardiac Care at University of Pennsylvania Medical Center-Presbyterian provide diagnostic catheterization services on-site in Shore Memorial’s recently opened CardioVascular Institute (CVI).
The CVI is located on the hospital’s second floor. An $8.5 million Institute, it includes some of the most advanced technology available and a team of nurses, technologists, cardiologists, radiologists and vascular surgeons se
Angiolink's Staple-Mediated VCD Addresses Limitations of Current Technology Part II
- Thu, 6/19/08 - 1:59pm
- 0 Comments
- 3977 reads
We designed the staple with a surgeon’s mentality, and chose titanium as the metal. Titanium is a very cheap, very inert metal that actually is what surgeons will implant most of the time with heart valves and with hip replacements. The staple is a very small, low-profile 3-mm staple. Figure 2 is really 3 millimeters, and portion A is designed to sit above the artery. The B portion is designed to actually implant into the outer walls of the vessel, avoiding the lumen of the vessel. This VCD is totally extraluminal in its action, which is one of its major advantages.
Closing the Vesse
- « Previous
- | Page 1 of 2 |
- Next »
